These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26187390)

  • 21. Assessment of the Tobacco Dependence Screener Among Smokeless Tobacco Users.
    Mushtaq N; Beebe LA
    Nicotine Tob Res; 2016 May; 18(5):885-91. PubMed ID: 26718743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smokeless and flavored tobacco products in the U.S.: 2009 Styles survey results.
    Regan AK; Dube SR; Arrazola R
    Am J Prev Med; 2012 Jan; 42(1):29-36. PubMed ID: 22176843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The appeal of smokeless tobacco products among young Canadian smokers: the impact of pictorial health warnings and relative risk messages.
    Callery WE; Hammond D; O'Connor RJ; Fong GT
    Nicotine Tob Res; 2011 May; 13(5):373-83. PubMed ID: 21357730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The assessment of tobacco dependence in young users of smokeless tobacco.
    DiFranza JR; Sweet M; Savageau JA; Ursprung WW
    Tob Control; 2012 Sep; 21(5):471-6. PubMed ID: 21712393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An epidemiologic review of smokeless tobacco health effects and harm reduction potential.
    Colilla SA
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):197-211. PubMed ID: 19796662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interviews with smokers about smokeless tobacco products, risk messages and news articles.
    Wackowski OA; Lewis MJ; Delnevo CD
    Tob Control; 2016 Nov; 25(6):671-678. PubMed ID: 26576840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beliefs and perceptions toward quitting waterpipe smoking among cafe waterpipe tobacco smokers in Bahrain.
    Borgan SM; Marhoon ZA; Whitford DL
    Nicotine Tob Res; 2013 Nov; 15(11):1816-21. PubMed ID: 23674839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multiple motive/multi-dimensional approach to measure smokeless tobacco dependence.
    Mushtaq N; Beebe LA; Vesely SK; Neas BR
    Addict Behav; 2014 Mar; 39(3):622-9. PubMed ID: 24333034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.
    Ayo-Yusuf OA; Burns DM
    Tob Control; 2012 Mar; 21(2):245-51. PubMed ID: 22345261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of social influences and tobacco availability on adolescent smokeless tobacco use.
    Boyle RG; Claxton AJ; Forster JL
    J Adolesc Health; 1997 Apr; 20(4):279-85. PubMed ID: 9098731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users.
    Post A; Gilljam H; Rosendahl I; Bremberg S; Galanti MR
    Addiction; 2010 Apr; 105(4):740-6. PubMed ID: 20148785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute and Relative Smokeless Tobacco Product Risk Perceptions: Developing and Validating New Measures that are Up-to-Snuff.
    O'Brien EK; Baig SA; Persoskie A
    Nicotine Tob Res; 2022 Feb; 24(2):265-269. PubMed ID: 34482405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Case to Include Brand of Moist Snuff in Health Surveys.
    Timberlake DS
    Nicotine Tob Res; 2016 Aug; 18(8):1786-90. PubMed ID: 27020059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of E-Cigarettes Among Current Smokers: Associations Among Reasons for Use, Quit Intentions, and Current Tobacco Use.
    Rutten LJ; Blake KD; Agunwamba AA; Grana RA; Wilson PM; Ebbert JO; Okamoto J; Leischow SJ
    Nicotine Tob Res; 2015 Oct; 17(10):1228-34. PubMed ID: 25589678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge of health effects and intentions to quit among smokeless tobacco users in India: findings from the International Tobacco Control Policy Evaluation (ITC) India Pilot Survey.
    Raute LJ; Sansone G; Pednekar MS; Fong GT; Gupta PC; Quah AC; Bansal-Travers M; Sinha DN
    Asian Pac J Cancer Prev; 2011; 12(5):1233-8. PubMed ID: 21875273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of snus in initiation and cessation of tobacco smoking in Sweden.
    Ramström LM; Foulds J
    Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.